It’s not the first question a parent asks. It’s likely not the fourth or fifth. But for parents like Brian and Diane Vollmert, the question of how to pay for their son, Scott, to receive the best care while providing for their family became an unmanageable challenge.
“From the very beginning, Scott didn’t fit cleanly in any category. He wasn’t clearly autistic. He wasn’t clearly developmentally delayed. He had characteristics of both,” said Diane. That combination of Autism Spectrum Disorder and developmental delay can add up to more than $2.4 million in care over Scott’s lifetime, according to a study published in the Journal of the American Medical Association’s Pediatrics last year. An astronomical sum for most Americans, including the Vollmerts.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7422152-northwestern-mutual-special-needs/
Find out what it is like to be a zombie. All you have to do is read The diary of Willie Adams as he experiences Zombie-hood. Find out more at http://www.AnneElizabeth.net. Power 3 Willie’s Journal by Anne Elizabeth Book Trailer Comic/horror
No conversation is more top-of-mind for today’s business and marketing leaders than the impact of social media on the changing face of business in this tough economy.
Simon Mainwaring, author of the New York Times, Wall Street Journal, and Amazon bestseller “We First: How Brands and Consumers use Social Media to Build a Better World”, is at the forefront of this discussion, as he proposes a vision for the re-purposing of the private sector that he characterizes as a shift from “Me-First” to “We-First” capitalism. So timely is his proposal that Amazon named it a Top 10 Business Book for 2011, and strategy+business named it their best Marketing Book of 2011, stating, “We First is that rare marketing book that is truly visionary.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/51616-we-first-social-branding-seminar-simon-mainwaring
When her father is killed by the notorious Rose Riders for a mysterious journal that reveals the secret location of a gold mine, eighteen year-old Kate Thompson disguises herself as a boy and takes to the gritty plains looking for answers—and justice. In the spirit of True Grit, acclaimed young adult novelist Erin Bowman brings to life the unpredictable and cutthroat days of the Wild West. Find out more at http://www.embowman.com/ and http://www.hmhco.com/ #VengeanceRoad historical romance/YA
Hoy se lanza lanuevaseriedelibros titulada BUENASALUD™,la cual trata sobre temas como la salud del corazón(prólogo por el CEOdelaAmerican College of Cardiology) y ladiabetes(prólogo por el CEOde laAsociaciónAmericanade Diabetes). Escritaporla Dra. JaneL.Delgado, Presidenta yDirectora Ejecutiva delaAlianzaNacionalpara laSalud de los Hispanos, esta serie de librosesla primera dedicada alas experienciasde saluddel creciente número de lectoreshispanos.Lasguíascuentanhistoriasde la vida realy ofreceninformaciónsobrela salud y los últimos avancesmédicospara enfermedadesy condiciones individuales,en untonocálidoyde conversación.
Don’t trust us, trust Science: Abbott is among the best science-based companies to work for in the world.
For the 13th consecutive year, the journal Science today recognized Abbott on its Top Employers list, evaluated on 23 characteristics including financial strength, easy adaptation to change and a having a research-driven environment.
”Abbott is unique in that we’ve been adding to our reservoir of scientific knowledge for 128 years,“ said John Frels, Ph.D., chair of Abbott’s Scientific Governing Board, which oversees the company’s senior scientific career track. ”We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today. This helps us to create new, breakthrough innovations that change people’s lives.“
To view the multimedia release go to:
http://www.multivu.com/players/English/7962251-science-names-abbott-2016-top-employer/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Rescue One Financial offers debt resolution services to help people in need of debt relief. We are hard-working people helping hard-working people, just like you. Our company has been named as one of the fastest growing companies in southern California by the Orange County Business Journal.
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
New research published in the September issue of the British Journal of Nutrition and featured in the just released Global Phytonutrient Report highlights a significant shortfall in fruit and vegetable consumption in people’s diets around the world. Commissioned by the Nutrilite Health Institute of Amway, the research finds the majority of adults worldwide would have to at least double their current consumption of fruits and vegetables to meet the World Health Organization’s minimum recommendation of five servings (400 grams) per day. Additionally, the vast majority of adults worldwide – 60 to 87 percent across 13 geographic diet regions – are falling short of this recommendation and missing out on crucial nutrition and health benefits.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7239454-nutrilite-health-institute-of-amway-research-reveals-adults-need-double-fruit-vegetable/
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu,’ even when given late in the course of illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/outcome/46648/
Cathay Che is a New York based travel writer who has blazed her way through about 50 countries (so far). She is also the author of the book, Deborah Harry: Platinum Blonde, the only authorized biography of the iconic Blondie frontwoman. She was a contributing editor at Time Out New York from 1995-2004, and is now a contributing editor at LEXUS magazine. She has been happily contributing her uncensored travel blog, TRAVEL JUNKIE: Addicted to a Taste of Strange, to MOLI.com for sixteen months. She has also written for concierge.com, DailyCandy.com, Brides, forbestraveler.com, Everyday With Rachel Ray, Budget Travel, Mens Journal, Details, Interview, InStyle, The New York Post travel section, The Honolulu Advertiser, men.style.com, and Glamour. As a performance artist, Che has appeared in New York at The Kitchen, PS 122, Dixon Place, WOW Cafe, Exit Art and The Public Theater. Her first media-related job was as the on-air movie reviewer for the cable TV show, Party Talk, from 1993-1996. Courtesy of cathayche on MOLI.com.
Visit cathayche in the MOLI View
